MFDS — authorised 15 September 2021
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: likely_approved
🇰🇷 Exkivity in South Korea
MFDS authorised Exkivity on 15 September 2021
Marketing authorisation
Exkivity in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Exkivity approved in South Korea?
Yes. MFDS authorised it on 15 September 2021.
Who is the marketing authorisation holder for Exkivity in South Korea?
TAKEDA PHARMS USA holds the South Korean marketing authorisation.